Table 1. Treatments, Nanoparticle Concentrations, and Abbreviation of Treatments Used^a.

no.	treatments	nanomaterial conc. (mg/L)	cyromazine conc. (mg/L)	abbreviation of treatments	abbreviation of poll treatments	dd-PCR	Q-PCR
1	control			C		+	+
2	cyromazine		25		P1	–	–
3			50	T1		+	+
4			100			–	–
5	cyromazine + WO3	100	25		P2	–	–
6			50	T2		+	+
7			100			–	–
8		500	25		P3	–	–
9			50	T3		+	+
10			100			–	–
11	cyromazine + MNP	100	25		P4	–	–
12			50	T4		+	+
13			100			–	–
14		500	25		P5	–	–
15			50	T5		+	+
16			100			–	–
17	cyromazine + MNP-Cu	100	25		P6	–	–
18			50	T6		+	+
19			100			–	–
20		500	25		P7	–	–
21			50	T7		+	+
22			100			–	–

^aWO₃, tungsten oxide nanoparticles; MNP, iron oxide nanoparticles; and MNP-Cu, Cu-doped iron oxide nanoparticles.